← Evidence map

ArticleScientific reports2021

A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells.

Nadine Aschmoneit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34230555